Selective VRK1 inhibition reduces glioblastoma growth via synthetic lethality in vitro and in vivo
European Journal of Cancer · 2026-11 · 248 · 117630
DOI: 10.1016/j.ejca.2026.117630 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von M. Singh und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Singh, M., Moussaud, S., Persson, L., Tresaugues, L., Roos, K., Talibov, V., Stantic, M., Gudoityte, G., Milito, A., Lindström, J., & Andersson, M. (2026). Selective VRK1 inhibition reduces glioblastoma growth via synthetic lethality in vitro and in vivo. European Journal of Cancer, 248, 117630. https://doi.org/10.1016/j.ejca.2026.117630
Vancouver
Singh M, Moussaud S, Persson L, Tresaugues L, Roos K, Talibov V, et al. Selective VRK1 inhibition reduces glioblastoma growth via synthetic lethality in vitro and in vivo. European Journal of Cancer. 2026;248:117630. doi:10.1016/j.ejca.2026.117630
BibTeX
@article{Singh2026,
author = {Singh, M. and Moussaud, S. and Persson, L.B. and Tresaugues, L. and Roos, K. and Talibov, V.O. and Stantic, M. and Gudoityte, G. and Milito, A.D. and Lindström, J. and Andersson, M.},
title = {Selective VRK1 inhibition reduces glioblastoma growth via synthetic lethality in vitro and in vivo},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117630},
doi = {10.1016/j.ejca.2026.117630}
}
EUVIMED